Susceptibility of exogenous surfactant to phospholipase A2 degradation.

The inhibition of surfactant biophysical activity in vivo is potentially mediated by many factors, including serum proteins, particularly enzymatic proteins such as phospholipases. In the present study, we investigated the susceptibility of the phosphatidylcholine component of two exogenous surfactants, Exosurf and Survanta, to secretory-type phospholipase A2 (PLA2) deacylation in vitro. Lyophilized Exosurf and Survanta preparations were incubated at 37 degrees C for 120 min in the presence of bovine pancreatic PLA2, and the production of lysophosphatidylcholine was determined as a measure of the magnitude of phosphatidylcholine deacylation. The phosphatidylcholine component of Survanta was readily deacylated by PLA2, whereas the dipalmitoylphosphatidycholine (DPPC) component of Exosurf was resistant over the entire duration of the assay. To further evaluate this observed resistance the individual and combined effects of tyloxapol and hexadecanol, components of Exosurf, upon PLA2 deacylation of Survanta and DPPC were investigated. In both Survanta and DPPC preparations, PLA2-mediated deacylation was significantly inhibited in the presence of tyloxapol. We conclude that the presence of tyloxapol in the Exosurf preparation inhibits secretory type PLA2 mediated DPPC deacylation. This unique feature of Exosurf may be of clinical significance when this preparation is utilized in the treatment of surfactant-deficient infants.

[1]  K. Thornburg,et al.  Atrial Myocardial Blood Flow during Acute Right Ventricular Pressure Load and Adenosine Infusion in Late Gestation Fetal Sheep , 1994, Pediatric Research.

[2]  L. Wright,et al.  A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network. , 1993, The Journal of pediatrics.

[3]  A. Jobe,et al.  Changes in exogenous surfactant in ventilated preterm lamb lungs. , 1993, The American review of respiratory disease.

[4]  C. Cross,et al.  Reduction of the surface-tension-lowering ability of surfactant after exposure to hypochlorous acid. , 1993, The Biochemical journal.

[5]  G. Enhorning,et al.  Phospholipases introduced into the hypophase affect the surfactant film outlining a bubble. , 1992, Journal of applied physiology.

[6]  D. Wilton,et al.  A study of the 14 kDa phospholipase A2 from rat liver using a continuous fluorescent displacement assay for the enzyme. , 1992, Biochemical Society transactions.

[7]  L. Agius,et al.  Triacylglycerol accumulation and secretion in hepatocyte cultures. Effects of insulin, albumin and Triton WR 1339. , 1992, The Biochemical journal.

[8]  J. Cummings,et al.  A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. , 1992, The American review of respiratory disease.

[9]  A. Romaschin,et al.  Systemic phospholipase A2 and cachectin levels in adult respiratory distress syndrome and multiple-organ failure. , 1992, Clinical biochemistry.

[10]  C. R. Reed,et al.  Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. , 1991, The Journal of clinical investigation.

[11]  G. Enhorning,et al.  Inhibition of pulmonary surfactant function by phospholipases. , 1991, Journal of applied physiology.

[12]  A. Jobe,et al.  Surfactant for the treatment of respiratory distress syndrome. , 1987, The American review of respiratory disease.

[13]  W. Tooley,et al.  Lung function in prematurely delivered rabbits treated with a synthetic surfactant. , 1987, The American review of respiratory disease.

[14]  G. Enhorning,et al.  Artificial pulmonary surfactant inhibited by proteins. , 1987, Journal of applied physiology.

[15]  A. Jobe,et al.  A protein from airways of premature lambs that inhibits surfactant function. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.

[16]  R. Verger,et al.  Novel intestinal phospholipase A2: purification and some molecular characteristics. , 1982, Biochemistry.

[17]  R. Spragg,et al.  Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. , 1982, The Journal of clinical investigation.

[18]  P. von Wichert,et al.  Influence of septic shock upon phosphatidylcholine remodeling mechanism in rat lung. , 1981, Biochimica et biophysica acta.

[19]  J. Padbury,et al.  Duration and characteristics of treatment of premature lambs with natural surfactant. , 1981, The Journal of clinical investigation.

[20]  King Rj.  The surfactant system of the lung. , 1974 .

[21]  J. Clements,et al.  Surface active materials from dog lung. II. Composition and physiological correlations. , 1972, The American journal of physiology.

[22]  R. Havel,et al.  Composition of surface-active material isolated from beef lung. , 1961, Proceedings of the National Academy of Sciences of the United States of America.